<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858167</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A00763-52</org_study_id>
    <nct_id>NCT02858167</nct_id>
  </id_info>
  <brief_title>Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations</brief_title>
  <acronym>BDD TEP FDG</acronym>
  <official_title>Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations: Study of Principal Inter-individual Variation Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to define a reference population for FDG-PET neurological
      examinations starting from patients having FDG-PET to supervise a non-complicated lymphoma
      (tumor in remission, low disabling chronic tumor).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will also check normality of cerebral functions in this population and analyse the
      influence of various variation factors, such as age, sex ratio, education level, professional
      activity and neuropsychological test results on normal data.

      This database could be later used as comparison to patient images defining the gravity and
      localization of their cerebral functional disorders.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of neurological impairment detected during standard neurological examination</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini-mental state score</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Frontal Assessment Battery score</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview (DSM-IV) score</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Montgomery-Åsberg depression rating scale</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of cerebral abnormalities detected with PET</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of cerebral abnormalities detected with X ray spiral CT</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Instrumental Activities of Daily Living evaluation</measure>
    <time_frame>Day 0</time_frame>
    <description>Evaluation of the normality of cerebral function in study population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral FDG distribution</measure>
    <time_frame>Day 0</time_frame>
    <description>Voxel-based analysis with SPM software of PET data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FDG mean activity in cerebral sections</measure>
    <time_frame>Day 0</time_frame>
    <description>Automatic measurement of FDG mean fixation in cerebral sections with NeurogamTM (Segami) software in PET data</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Lymphoma</condition>
  <arm_group>
    <arm_group_label>FDG-PET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FDG-PET</intervention_name>
    <description>FDG injection followed by cerebral examination with X ray spiral CT after 40 minutes and FDG-PET after 60 minutes</description>
    <arm_group_label>FDG-PET</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with tumor in remission or low disabling chronic tumor

          -  No parenteral chemotherapy for at least 1 month

          -  No glucocorticoid treatment

          -  No general health modification (asthenia, anorexia, weight reduction)

        Exclusion Criteria:

          -  Patient having a known neurodegenerative disorder, a general disease or physical
             problems that can interfere with cognitive function

          -  Patient with cerebral pathology history (epilepsy, vascular event, cerebral vascular
             malformation, tumor, severe cranial trauma, meningitis or infectious or inflammatory
             encephalitis, hydrocephalus, mental retardation…)

          -  Patient not having at least 4 years of education

          -  Patient having an anxiolytic or anti-depressive treatment

          -  Patient refusing to participate to the study

          -  Patient incapable to give informed consent (guardianship)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Hélène Laurens</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Nucléaire, Hôpital Central, Nancy, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre-Yves MARIE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Nucléaire, Hôpital Central, Nancy, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Médecine Nucléaire, Hôpital Central</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>September 13, 2016</last_update_submitted>
  <last_update_submitted_qc>September 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
    <mesh_term>Deoxyglucose</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

